What H. pylori actually does
H. pylori doesn't damage the stomach in one dramatic event. It's a slow, methodical process.
When H. pylori enters the stomach, it immediately faces the problem of high acidity. Its survival mechanism is an enzyme called urease, which converts urea into ammonia — a base that neutralises acid locally, creating a protected zone. This is how H. pylori survives where most bacteria would die instantly.[1]
Urease enzymeOnce it has neutralised its local environment, H. pylori uses specialised surface proteins to attach itself directly to the epithelial cells of the stomach wall. This adhesion is what allows it to persist despite the stomach's normal motility and acid — it becomes structurally embedded rather than just floating in the gastric fluid.
Mucosal adhesionH. pylori then triggers the immune system. The body recognises the bacteria as a threat and sends white blood cells to attack. But H. pylori has evolved ways to survive this immune assault — the inflammation persists, and the collateral damage to stomach cells accumulates over months and years. This is how gastritis develops.[3]
NF-kB cascadeOver time, chronic inflammation erodes the mucus-producing cells. The mucus layer — your stomach's main defence — becomes thinner and less effective. Stomach acid now has more direct contact with the stomach wall. This is the mechanism behind most H. pylori-related symptoms: burning, pain, sensitivity to food, worsening acidity.
Mucosal thinningH. pylori's damage is cumulative and structural. It uses urease to survive, adhesion proteins to anchor, immune dysregulation to persist, and chronic inflammation to progressively erode the mucosal barrier. Each step makes the next worse — and none of it is addressed by reducing stomach acid alone.
What antacids actually do (and don't do)
Antacids work by neutralising stomach acid. They are very effective at what they do.
What they don't do:
- Eliminate H. pylori from the stomach
- Repair the damaged mucosal lining
- Reduce the inflammation caused by the immune response
- Restore the mucus-producing cells that H. pylori has damaged
In other words, antacids treat the symptom. They do not address any part of the mechanism causing it.
PPIs (proton pump inhibitors like omeprazole) are stronger — they reduce acid production at the source. But they have the same limitation: the bacteria is still there, the lining is still damaged, the inflammation is still active.[4]
Antacids are the right tool for occasional, dietary-triggered acidity. They are the wrong tool for acidity caused by bacterial damage to the stomach lining. Knowing which category your symptoms fall into is what determines whether an antacid will solve your problem — or just delay it.
What the stomach lining actually needs
For the stomach to recover from H. pylori, two things need to happen:
- The bacteria needs to be addressed — either through antibiotics or compounds that inhibit H. pylori's survival mechanisms
- The damaged stomach lining needs support to recover — mucus production needs to be restored, inflammation needs to be reduced, and epithelial cells need to regenerate
This is where the science of flavonoids becomes relevant. Specific flavonoids have been shown in peer-reviewed research to stimulate prostaglandin production, support mucus-secreting cells, and activate the EGFR/ERK molecular pathway that promotes stomach epithelial repair.[2]
How long does stomach lining recovery take?
Once H. pylori is addressed, the stomach lining can begin to recover — but it takes time. Minor mucosal inflammation typically improves within weeks of treatment. More significant damage can take months of consistent support to meaningfully recover.
This is why a 60-day course is more meaningful than a 1-week fix. The bacteria is addressed in the first few weeks. Creating the environment for stomach lining recovery happens over the weeks and months that follow.
References
- Mobley HL. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Alimentary Pharmacology & Therapeutics. 1996;10 Suppl 1:57–64. PMID 8730257. Establishes the urease-ammonia mechanism as the primary survival strategy enabling H. pylori to persist in the acidic stomach environment.
- Amieva M, Peek RM Jr. Pathogenesis of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64–78. PMC4691563. Details the molecular pathways by which H. pylori causes progressive mucosal damage, including EGFR/ERK signalling and prostaglandin modulation.
- Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews. 2006;19(3):449–490. PMC1539101. Comprehensive review of H. pylori pathogenesis including adhesion mechanisms, immune evasion, and the development of chronic gastritis.
- Strand DS, Kim D, Peura DA. 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver. 2017;11(1):27–37. PMC5221858. Reviews the mechanism and limitations of PPIs, confirming they suppress acid but do not eliminate H. pylori or address mucosal damage.
The four-step damage mechanism is drawn from clinical microbiology literature (Kusters et al., 2006; Amieva & Peek, 2016) and is well-established in academic gastroenterology. The claim that antacids and PPIs do not address the underlying bacterial or mucosal mechanisms is supported by Strand et al. (2017). The TumGard India Gut Health Report 2026 adds the demand-side dimension: in a cohort of 2,263 symptomatic Indian adults, 54% were already on regular antacid or PPI medication and remained symptomatic.